Evolving Therapies in the Clinical Management of Melanoma
Presented by Lisa A. Kottschade, APRN, MSN, CNP, and Svetomir N. Markovic, MD, PhD
Mayo Clinic, Rochester, Minnesota
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2019;10(3):252–255 |
© 2019 Harborside™
Lisa A. Kottschade, APRN, MSN, CNP, and Svetomir N. Markovic, MD, PhD, shared clinical data supporting the use of emerging targeted therapies and immunotherapies in the treatment of metastatic melanoma.
For access to the full length article, please sign in